| Literature DB >> 33147836 |
Ragini Kothari1, Yuman Fong1, Michael C Storrie-Lombardi2,3.
Abstract
Laser Raman spectroscopy (LRS) is a highly specific biomolecular technique which has been shown to have the ability to distinguish malignant and normal breast tissue. This paper discusses significant advancements in the use of LRS in surgical breast cancer diagnosis, with an emphasis on statistical and machine learning strategies employed for precise, transparent and real-time analysis of Raman spectra. When combined with a variety of "machine learning" techniques LRS has been increasingly employed in oncogenic diagnostics. This paper proposes that the majority of these algorithms fail to provide the two most critical pieces of information required by the practicing surgeon: a probability that the classification of a tissue is correct, and, more importantly, the expected error in that probability. Stochastic backpropagation artificial neural networks inherently provide both pieces of information for each and every tissue site examined by LRS. If the networks are trained using both human experts and an unsupervised classification algorithm as gold standards, rapid progress can be made understanding what additional contextual data is needed to improve network classification performance. Our patients expect us to not simply have an opinion about their tumor, but to know how certain we are that we are correct. Stochastic networks can provide that information.Entities:
Keywords: Raman spectroscopy; breast cancer; multivariate statistics; neural networks
Mesh:
Year: 2020 PMID: 33147836 PMCID: PMC7663399 DOI: 10.3390/s20216260
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Energy level diagram of the Raman effect.
Figure 2The data processing steps required for robust Raman spectral analysis with the various algorithms that can be used for each step.
Figure 3Flowchart example of data processing for LRS breast tissue signals.
Biomolecular assignments of six regions of interest in spectra displayed in Figure 3.
| Region of Interest | Raman Shift (cm−1) | Biomolecular Assignment * [ |
|---|---|---|
| v1 | 780–810 | O—P—O stretching DNA, ring breathing mode U, T, C bases of RNA and DNA |
| v2 | 815–825 | C—C stretch of proline and hydroxyproline, out of plane ring breathing of tyrosine |
| v3 | 1302 | assigned to CH2 twisting of lipids in healthy; in tumor assigned to CH2 twisting in proteins or amide III (protein) |
| v4 | 1441 | CH2 bending mode in lipids |
| v4 | 2853 | CH2 symmetric stretch of lipids |
| v4 | 2903 | CH2 asymmetric stretch of lipids and proteins |
* See Movasaghi et al. [53], and references therein.
Summary of major research findings in use of LRS for breast cancer diagnostics.
| Author | Tissue Type, Number of Patients, Number of Spectra | LRS System | Algorithm | Prediction Statistics | Findings |
|---|---|---|---|---|---|
| Shafer-Peltier et al. [ | Ex vivo normal, benign and malignant tissue; | 830 nm; Raman confocal microscope | Non-Negative Least squares fitting, PCA | N/A | Nine basis spectra; Raman micro spectroscopic model compared to H&E findings |
| Haka et al. [ | Ex vivo microcalcifications | 830 nm | PCA | Sensitivity = 88% specificity = 93% for determining microcalcifications in malignant and benign ducts | Type ΙΙ microcalcifications in benign ducts have more calcium carbonate and less protein than type ΙΙ microcalcifications in malignant ducts |
| Haka et al. [ | Ex vivo normal, fibrocystic change, fibroadenoma, | 830 nm | Linear combination of basis spectra, logistic regression, diagnostic algorithm based on fat and collagen content | Sensitivity = 94% specificity = 96% for infiltrating carcinoma | 9 basis spectra; Fit coefficients for each basis spectra highlight chemical and morphological |
| Haka et al. [ | In vivo breast tissue during partial mastectomy; nine patients; 31 spectra | 830 nm | Linear combination of basis spectra, logistic regression, diagnostic algorithm based on fat and collagen content | Sensitivity and specificity = 100% for carcinoma, only one malignant spectrum | In vivo spectra collected in 1 s; if malignant spectrum was taken into account during initial surgery second surgery could have been avoided |
| Mohs et al. [ | In vivo mouse model; injected with 4T1 tumor cell line and ICG and SERS contrast agents; 14 in vivo spectra | SpectroPen at 785 nm | Linear regression model | N/A | Descriptive development of hand-held SpectroPen compared to normal 785 LRS system |
| Keller et al. [ | 35 in vitro tissue samples | Spatially offset 785 nm LRS system; probe design discussed | Sparse multinomial logistic regression | Sensitivity = 95% specificity = 100% for discerning positive and negative margins | SORS allows collection of photons from deeper within the sample |
| Brozek-Pluska et al. [ | Ex vivo breast tissue; 44 patients; 321 spectra | 514 nm | Least squares fitting, PCA | Sensitivity = 72% for malignant tissue; sensitivity = 62% for benign | Specific band and band ratio differences in malignant, normal and benign tissue discussed, malignant spectra has more autofluorescence |
| Abramczyk et al. [ | Ex vivo breast tissue; 99 patients; 1100 spectra | 514 nm | Least squares fitting, PCA | Sensitivity = 72% for malignant tissue; sensitivity = 62% for benign | Same as Brozek-Pluska above |
| Shipp et al. [ | 51 fresh whole BCS specimens | 405 nm confocal microscope for autofluoresence (AF) images, 785 nm system for Raman spectra | Unsupervised algorithm to detect segments in AF images; K-means, LDA | Sensitivity = 100% and specificity is at least 80% for multimodal spectral histopathology for 51 BCS surfaces | Results were obtained within an intraoperative timescale (12–24 min), diagnosis model trained on smaller mastectomy samples with sensitivity = 91% and specificity = 83% |
| Garcia-Flores et al. [ | Ex vivo and in vivo breast tissue of rats | High-frequency (HF) Fourier transform LRS system at 1064 nm | PCA, LDA | Discrimination accuracy of 77.2%, 82.3% and 100% for in vivo transcutaneous, in vivo skin-removed and ex vivo spectra respectively | HF Raman spectra has a shorter acquisition time due to more intense signal in this region, HF region has no interfering signal from optical fiber |
| Zúñiga et al. [ | Ex vivo breast tissue; six patients; 164 spectra | 785 nm and 1064 commercially available systems | PCA, LDA | Sensitivity = 90% specificity = 86% with 785 nm system without microscope | Systematic comparison of 1064 and 785 nm systems with and without microscope; discussion of importance of high wavenumber signals |
| Barman et al. [ | Ex vivo breast tissue; 33 patients undergoing stereotactic core needle breast biopsy procedures; 146 tumor sites | 830 nm | SVM | Sensitivity = 62.5% specificity = 100% | SVM and LRS have been used to identify normal tissue, fibrocystic change (FCC), fibroadenoma (FA) and breast cancer, in the absence and presence of microcalcifications |
| Lyng et al. [ | Ex vivo benign lesions (fibrocystic, fibroadenoma, intraductal papilloma) and cancer (invasive ductal carcinoma and lobular carcinoma); 20 patients | 532 nm | PCA, LDA, QDA (quadratic discriminant analysis), SVM, Partial least squares discriminant analysis (PLSDA) | Sensitivity = 83% and specificity = 80% (PCA-LDA and PCA-QDA); Sensitivity = 82% and specificity = 84% (PLSDA) | Study also included immunohistochemical staining for ER and HER2 receptor |
| Shang et al. [ | Ex vivo breast tissue; 14 patients | 785 nm | CNN on autofluorescence images, BP-NN on Raman spectra, PLS | Discrimination accuracy of 95.33% and 98.67% respectively for collagen and lipid BP-NNs | Auto florescence images and Raman spectra fed into PLS model to achieve 100% accuracy |
| Koya et al. [ | Ex vivo basal and luminal breast cancer samples | 785 nm | CNN with one hidden layer | Sensitivity = 88.8% and specificity = 90.8% for discriminating cancerous and normal breast tissue | Specific band differences discussed |